-
1
-
-
0026734529
-
Potential pathogenicity for rodents of vaccines intended for oral vaccination against rabies: a comparison
-
Artois M., Guittre C., Thomas I., Leblois H., Brochier B., Barrat J. Potential pathogenicity for rodents of vaccines intended for oral vaccination against rabies: a comparison. Vaccine 1992, 10:524-528.
-
(1992)
Vaccine
, vol.10
, pp. 524-528
-
-
Artois, M.1
Guittre, C.2
Thomas, I.3
Leblois, H.4
Brochier, B.5
Barrat, J.6
-
2
-
-
23444448769
-
High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoreactive activity in mice
-
Ashraf S., Singh P.K., Yadav D.K., et al. High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoreactive activity in mice. Journal of Biotechnology 2005, 119:1-14.
-
(2005)
Journal of Biotechnology
, vol.119
, pp. 1-14
-
-
Ashraf, S.1
Singh, P.K.2
Yadav, D.K.3
-
3
-
-
0032007830
-
DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses
-
Bahloul C., Jacob Y., Tordo N., Perrin P. DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses. Vaccine 1998, 16:417-425.
-
(1998)
Vaccine
, vol.16
, pp. 417-425
-
-
Bahloul, C.1
Jacob, Y.2
Tordo, N.3
Perrin, P.4
-
4
-
-
0034783743
-
Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine
-
Biswas S., Reddy G.S., Srinivasan V.A., Rangarajan P.N. Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine. Human Gene Therapy 2001, 12:1917-1922.
-
(2001)
Human Gene Therapy
, vol.12
, pp. 1917-1922
-
-
Biswas, S.1
Reddy, G.S.2
Srinivasan, V.A.3
Rangarajan, P.N.4
-
5
-
-
0029101407
-
Elimination of fox rabies from Belgium using a recombinant vaccinia-rabies glycoprotein vaccine; an update
-
Brochier B., Costy F., Pastoret P.-P. Elimination of fox rabies from Belgium using a recombinant vaccinia-rabies glycoprotein vaccine; an update. Veterinary Microbiology 1995, 46:269-279.
-
(1995)
Veterinary Microbiology
, vol.46
, pp. 269-279
-
-
Brochier, B.1
Costy, F.2
Pastoret, P.-P.3
-
6
-
-
0026315546
-
Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine
-
Brochier B., Kieny M.P., Costy F., et al. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature 1991, 354:520-522.
-
(1991)
Nature
, vol.354
, pp. 520-522
-
-
Brochier, B.1
Kieny, M.P.2
Costy, F.3
-
7
-
-
0025357435
-
Use of vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies
-
Brochier B., Thomas I., Bauduin B., et al. Use of vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies. Vaccine 1990, 8:101-104.
-
(1990)
Vaccine
, vol.8
, pp. 101-104
-
-
Brochier, B.1
Thomas, I.2
Bauduin, B.3
-
8
-
-
19944370132
-
Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3
-
Brzózka K., Finke S., Conzelmann K.-K. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. Journal of Virology 2005, 79:7673-7681.
-
(2005)
Journal of Virology
, vol.79
, pp. 7673-7681
-
-
Brzózka, K.1
Finke, S.2
Conzelmann, K.-K.3
-
9
-
-
0026762697
-
Immunisation with canarypox virus expressing rabies glycoprotein
-
Cadoz M., Strady A., Meignier B., et al. Immunisation with canarypox virus expressing rabies glycoprotein. Lancet 1992, 339:1429-1432.
-
(1992)
Lancet
, vol.339
, pp. 1429-1432
-
-
Cadoz, M.1
Strady, A.2
Meignier, B.3
-
10
-
-
0142088791
-
Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses
-
Chare E.R., Gould E.A., Holmes E.C. Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses. Journal of General Virology 2003, 84:1703-2691.
-
(2003)
Journal of General Virology
, vol.84
, pp. 1703-2691
-
-
Chare, E.R.1
Gould, E.A.2
Holmes, E.C.3
-
11
-
-
0026450108
-
Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine
-
Charlton K.M., Artois M., Prevec L., et al. Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Archives of Virology 1992, 123:169-179.
-
(1992)
Archives of Virology
, vol.123
, pp. 169-179
-
-
Charlton, K.M.1
Artois, M.2
Prevec, L.3
-
12
-
-
33645069647
-
Compendium of Animal Rabies Virus Prevention and Control, 2006
-
Compendium
-
Compendium Compendium of Animal Rabies Virus Prevention and Control, 2006. Journal of the American Veterinary Medical Association 2006, 228:858-864.
-
(2006)
Journal of the American Veterinary Medical Association
, vol.228
, pp. 858-864
-
-
-
13
-
-
0028115842
-
Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteins
-
Conzelmann K.-K., Schnell M. Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteins. Journal of Virology 1994, 68:713-719.
-
(1994)
Journal of Virology
, vol.68
, pp. 713-719
-
-
Conzelmann, K.-K.1
Schnell, M.2
-
14
-
-
0024999192
-
Use of vaccinia rabies recombinant for oral vaccination of wildlife
-
Desmettre P., Languet B., Chappuis G., et al. Use of vaccinia rabies recombinant for oral vaccination of wildlife. Veterinary Microbiology 1990, 23:227-232.
-
(1990)
Veterinary Microbiology
, vol.23
, pp. 227-232
-
-
Desmettre, P.1
Languet, B.2
Chappuis, G.3
-
15
-
-
0036318305
-
New approaches to the development of live attenuated rabies vaccines
-
Dietzschold B., Schnell M.J. New approaches to the development of live attenuated rabies vaccines. Hybrid Hybridomics 2002, 21:129-134.
-
(2002)
Hybrid Hybridomics
, vol.21
, pp. 129-134
-
-
Dietzschold, B.1
Schnell, M.J.2
-
16
-
-
0020670707
-
Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus
-
Dietzschold B., Wunner W.H., Wiktor T.J., et al. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proceedings of the National Academy of Sciences USA 1983, 80:70-74.
-
(1983)
Proceedings of the National Academy of Sciences USA
, vol.80
, pp. 70-74
-
-
Dietzschold, B.1
Wunner, W.H.2
Wiktor, T.J.3
-
17
-
-
7744237275
-
In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife
-
Dietzschold M.-L., Faber M., Mattis J.A., Pak K.Y., Schnell M.J., Dietzschold B. In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife. Vaccine 2004, 23:518-524.
-
(2004)
Vaccine
, vol.23
, pp. 518-524
-
-
Dietzschold, M.-L.1
Faber, M.2
Mattis, J.A.3
Pak, K.Y.4
Schnell, M.J.5
Dietzschold, B.6
-
18
-
-
0030973578
-
DNA vaccines
-
Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Annual Review of Immunology 1997, 15:617-648.
-
(1997)
Annual Review of Immunology
, vol.15
, pp. 617-648
-
-
Donnelly, J.J.1
Ulmer, J.B.2
Shiver, J.W.3
Liu, M.A.4
-
19
-
-
0024042540
-
Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein
-
Esposito J.J., Knight J.C., Shaddock J.H., Novembre F.J., Baer G.M. Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein. Virology 1988, 165:313-316.
-
(1988)
Virology
, vol.165
, pp. 313-316
-
-
Esposito, J.J.1
Knight, J.C.2
Shaddock, J.H.3
Novembre, F.J.4
Baer, G.M.5
-
20
-
-
0036124248
-
Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response
-
Faber M., Pulmanausahakul R., Hodawadekar S.S., et al. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. Journal of Virology 2002, 76:3374-3381.
-
(2002)
Journal of Virology
, vol.76
, pp. 3374-3381
-
-
Faber, M.1
Pulmanausahakul, R.2
Hodawadekar, S.S.3
-
21
-
-
0026507602
-
Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein
-
Fekadu M., Sumner J.W., Shaddock J.H., Sanderlin D.W., Baer G.M. Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein. Journal of Virology 1992, 66:2601-2604.
-
(1992)
Journal of Virology
, vol.66
, pp. 2601-2604
-
-
Fekadu, M.1
Sumner, J.W.2
Shaddock, J.H.3
Sanderlin, D.W.4
Baer, G.M.5
-
22
-
-
0029947256
-
Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system
-
Fries L.F., Tartaglia J., Taylor J., et al. Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system. Vaccine 1996, 14:428-434.
-
(1996)
Vaccine
, vol.14
, pp. 428-434
-
-
Fries, L.F.1
Tartaglia, J.2
Taylor, J.3
-
23
-
-
0028318858
-
Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein
-
Fujii H., Takita-Sonoda Y., Mifune K., Hirai K., Nishizono A., Mannen K. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein. Journal of General Virology 1994, 75:1339-1344.
-
(1994)
Journal of General Virology
, vol.75
, pp. 1339-1344
-
-
Fujii, H.1
Takita-Sonoda, Y.2
Mifune, K.3
Hirai, K.4
Nishizono, A.5
Mannen, K.6
-
24
-
-
0028038426
-
MHC-dependent antigen processing and peptide presentation: providing ligands for lymphocyte activation
-
Germain R.N. MHC-dependent antigen processing and peptide presentation: providing ligands for lymphocyte activation. Cell 1994, 76:287-299.
-
(1994)
Cell
, vol.76
, pp. 287-299
-
-
Germain, R.N.1
-
26
-
-
0036547702
-
Oral efficacy of an attenuated rabies virus vaccine in skunks and raccoons
-
Hanlon C.A., Niezgoda M., Morril P., Rupprecht C.E. Oral efficacy of an attenuated rabies virus vaccine in skunks and raccoons. Journal of Wildlife Diseases 2002, 38:420-427.
-
(2002)
Journal of Wildlife Diseases
, vol.38
, pp. 420-427
-
-
Hanlon, C.A.1
Niezgoda, M.2
Morril, P.3
Rupprecht, C.E.4
-
28
-
-
0032889310
-
Chimeric lyssavirus glycoproteins with increased immunological potential
-
Jallet C., Jacob Y., Bahloul C., et al. Chimeric lyssavirus glycoproteins with increased immunological potential. Journal of Virology 1999, 73:225-233.
-
(1999)
Journal of Virology
, vol.73
, pp. 225-233
-
-
Jallet, C.1
Jacob, Y.2
Bahloul, C.3
-
29
-
-
0021231509
-
Expression of rabies virus glycoprotein from a recombinant vaccinia virus
-
Kieny M.-P., Lathe R., Drillien R., et al. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 1984, 312:163-166.
-
(1984)
Nature
, vol.312
, pp. 163-166
-
-
Kieny, M.-P.1
Lathe, R.2
Drillien, R.3
-
30
-
-
0035925697
-
The green revolution: plants as heterologous expression vectors
-
Koprowski H., Yusibov V. The green revolution: plants as heterologous expression vectors. Vaccine 2001, 19:2735-2741.
-
(2001)
Vaccine
, vol.19
, pp. 2735-2741
-
-
Koprowski, H.1
Yusibov, V.2
-
31
-
-
0035925677
-
Post-exposure DNA vaccination protects mice against rabies virus
-
Lodmell D.L., Ewalt L.C. Post-exposure DNA vaccination protects mice against rabies virus. Vaccine 2001, 19:2468-2473.
-
(2001)
Vaccine
, vol.19
, pp. 2468-2473
-
-
Lodmell, D.L.1
Ewalt, L.C.2
-
32
-
-
4043174189
-
Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals
-
Lodmell D.L., Esposito J.J., Ewalt L.C. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals. Vaccine 2004, 22:3329-3333.
-
(2004)
Vaccine
, vol.22
, pp. 3329-3333
-
-
Lodmell, D.L.1
Esposito, J.J.2
Ewalt, L.C.3
-
33
-
-
0035852336
-
One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination
-
Lodmell D.L., Parnell M.J., Bailey J.R., Ewalt L.C., Hanlon C.A. One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination. Vaccine 2002, 20:838-844.
-
(2002)
Vaccine
, vol.20
, pp. 838-844
-
-
Lodmell, D.L.1
Parnell, M.J.2
Bailey, J.R.3
Ewalt, L.C.4
Hanlon, C.A.5
-
34
-
-
0037157271
-
Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers
-
Lodmell D.L., Parnell M.J., Bailey J.R., Ewalt L.C., Hanlon C.A. Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers. Vaccine 2002, 20:2221-2228.
-
(2002)
Vaccine
, vol.20
, pp. 2221-2228
-
-
Lodmell, D.L.1
Parnell, M.J.2
Bailey, J.R.3
Ewalt, L.C.4
Hanlon, C.A.5
-
35
-
-
0242380404
-
Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody
-
Lodmell D.L., Parnell M.J., Weyhrich J.T., Ewalt L.C. Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody. Vaccine 2003, 21:3998-4002.
-
(2003)
Vaccine
, vol.21
, pp. 3998-4002
-
-
Lodmell, D.L.1
Parnell, M.J.2
Weyhrich, J.T.3
Ewalt, L.C.4
-
36
-
-
0031986189
-
Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection
-
Lodmell D.L., Ray N.B., Ewalt L.C. Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection. Vaccine 1998, 16:115-118.
-
(1998)
Vaccine
, vol.16
, pp. 115-118
-
-
Lodmell, D.L.1
Ray, N.B.2
Ewalt, L.C.3
-
37
-
-
0031928759
-
DNA immunization protects non-human primates against rabies virus
-
Lodmell D.L., Ray N.B., Parnell M.J., et al. DNA immunization protects non-human primates against rabies virus. Nature Medicine 1998, 4:949-952.
-
(1998)
Nature Medicine
, vol.4
, pp. 949-952
-
-
Lodmell, D.L.1
Ray, N.B.2
Parnell, M.J.3
-
38
-
-
0033990172
-
DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL®)
-
Lodmell D.L., Ray N.B., Ulrich J.T., Ewalt L.C. DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL®). Vaccine 2000, 18:1059-1066.
-
(2000)
Vaccine
, vol.18
, pp. 1059-1066
-
-
Lodmell, D.L.1
Ray, N.B.2
Ulrich, J.T.3
Ewalt, L.C.4
-
39
-
-
0028863460
-
Expression of the rabies virus glycoprotein in transgenic tomatoes
-
McGarvey P.B., Hammond J., Denelt M.M., et al. Expression of the rabies virus glycoprotein in transgenic tomatoes. Biotechnology 1995, 13:1484-1487.
-
(1995)
Biotechnology
, vol.13
, pp. 1484-1487
-
-
McGarvey, P.B.1
Hammond, J.2
Denelt, M.M.3
-
40
-
-
0035163919
-
Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein
-
Mebatsion T. Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein. Journal of Virology 2001, 75:11496-11502.
-
(2001)
Journal of Virology
, vol.75
, pp. 11496-11502
-
-
Mebatsion, T.1
-
41
-
-
0032889562
-
Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G
-
Mebatsion T., Weiland F., Conzelmann K.-K. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. Journal of Virology 1999, 73:242-250.
-
(1999)
Journal of Virology
, vol.73
, pp. 242-250
-
-
Mebatsion, T.1
Weiland, F.2
Conzelmann, K.-K.3
-
43
-
-
0035858125
-
Genetic engineering of live rabies vaccines
-
Morimoto K., McGettigan J.P., Foley H.D., Hooper D.C., Dietzschold B., Schnell M.J. Genetic engineering of live rabies vaccines. Vaccine 2001, 19:3543-3551.
-
(2001)
Vaccine
, vol.19
, pp. 3543-3551
-
-
Morimoto, K.1
McGettigan, J.P.2
Foley, H.D.3
Hooper, D.C.4
Dietzschold, B.5
Schnell, M.J.6
-
44
-
-
19444368893
-
Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity
-
Morimoto K., Shoji Y., Inoue S. Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity. Virus Research 2005, 111:61-67.
-
(2005)
Virus Research
, vol.111
, pp. 61-67
-
-
Morimoto, K.1
Shoji, Y.2
Inoue, S.3
-
45
-
-
0037726752
-
A comparison of DNA vaccines for the rabies-related virus, Mokola
-
Nel L.H., Niezgoda M., Hanlon C.A., Morril P.A., Yager P.A., Rupprecht C.E. A comparison of DNA vaccines for the rabies-related virus, Mokola. Vaccine 2003, 21:2598-2606.
-
(2003)
Vaccine
, vol.21
, pp. 2598-2606
-
-
Nel, L.H.1
Niezgoda, M.2
Hanlon, C.A.3
Morril, P.A.4
Yager, P.A.5
Rupprecht, C.E.6
-
46
-
-
0033525601
-
Immunization of dogs and cats with a DNA vaccine against rabies virus
-
Osorio J.E., Tomlinson C.C., Frank R.S., et al. Immunization of dogs and cats with a DNA vaccine against rabies virus. Vaccine 1999, 17:1109-1116.
-
(1999)
Vaccine
, vol.17
, pp. 1109-1116
-
-
Osorio, J.E.1
Tomlinson, C.C.2
Frank, R.S.3
-
47
-
-
0032825504
-
Immunization of dogs with a DNA vaccine induces protection against rabies virus
-
Perrin P., Jacob Y., Aguilar-Sétien A., et al. Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine 2000, 18:479-486.
-
(2000)
Vaccine
, vol.18
, pp. 479-486
-
-
Perrin, P.1
Jacob, Y.2
Aguilar-Sétien, A.3
-
48
-
-
0025097853
-
A recombinant human adenovirus vaccine against rabies
-
Prevec L., Campbell J.B., Christie B., Belbeck L., Graham F.L. A recombinant human adenovirus vaccine against rabies. Journal of Infectious Diseases 1990, 161:27-30.
-
(1990)
Journal of Infectious Diseases
, vol.161
, pp. 27-30
-
-
Prevec, L.1
Campbell, J.B.2
Christie, B.3
Belbeck, L.4
Graham, F.L.5
-
49
-
-
0034766467
-
Overexpression of cytochrome c by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity
-
Pulmanausahakul R., Faber M., Morimoto K., et al. Overexpression of cytochrome c by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity. Journal of Virology 2001, 75:10800-10807.
-
(2001)
Journal of Virology
, vol.75
, pp. 10800-10807
-
-
Pulmanausahakul, R.1
Faber, M.2
Morimoto, K.3
-
50
-
-
0024116781
-
Efficacy of vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor)
-
Rupprecht C.E., Hamir A.N., Johnston D.H., Koprowski H. Efficacy of vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). Review of Infectious Diseases 1988, 10(Suppl 4):S803-S809.
-
(1988)
Review of Infectious Diseases
, vol.10
, Issue.SUPPL.4
-
-
Rupprecht, C.E.1
Hamir, A.N.2
Johnston, D.H.3
Koprowski, H.4
-
51
-
-
21144451217
-
Oral vaccination of dogs with recombinant rabies virus vaccines
-
Rupprecht C.E., Hanlon C.A., Blanton J., et al. Oral vaccination of dogs with recombinant rabies virus vaccines. Virus Research 2005, 111:101-105.
-
(2005)
Virus Research
, vol.111
, pp. 101-105
-
-
Rupprecht, C.E.1
Hanlon, C.A.2
Blanton, J.3
-
52
-
-
0011321735
-
Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine
-
Rupprecht C.E., Wiktor T.J., Johnston D.H., et al. Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proceedings of the National Academy of Sciences USA 1986, 83:7947-7950.
-
(1986)
Proceedings of the National Academy of Sciences USA
, vol.83
, pp. 7947-7950
-
-
Rupprecht, C.E.1
Wiktor, T.J.2
Johnston, D.H.3
-
53
-
-
0033812475
-
Building better vaccines: how apoptotic cell death can induce inflammation and active innate and adaptive immunity
-
Rustifo N.P. Building better vaccines: how apoptotic cell death can induce inflammation and active innate and adaptive immunity. Current Opinions in Immunology 2000, 12:597-603.
-
(2000)
Current Opinions in Immunology
, vol.12
, pp. 597-603
-
-
Rustifo, N.P.1
-
55
-
-
0036059866
-
Single oral immunization with replication deficient recombinant adenovirus elicicts long-lived transgene-specific cellular and humoral immune responses
-
Sharpe S., Fooks A., Lee J., Hayes K., Clegg C., Cranage M. Single oral immunization with replication deficient recombinant adenovirus elicicts long-lived transgene-specific cellular and humoral immune responses. Virology 2002, 293:210-216.
-
(2002)
Virology
, vol.293
, pp. 210-216
-
-
Sharpe, S.1
Fooks, A.2
Lee, J.3
Hayes, K.4
Clegg, C.5
Cranage, M.6
-
57
-
-
1242319455
-
Generation and characterization of P gene-deficient rabies virus
-
Shoji Y., Inoue S., Nakamichi K., Kurane I., Sakai T., Morimoto K. Generation and characterization of P gene-deficient rabies virus. Virology 2004, 318:295-305.
-
(2004)
Virology
, vol.318
, pp. 295-305
-
-
Shoji, Y.1
Inoue, S.2
Nakamichi, K.3
Kurane, I.4
Sakai, T.5
Morimoto, K.6
-
58
-
-
0022006293
-
Rabies virus virulence: effect on pathogenicity and sequence characterization of mutations affecting antigenic site III of the glycoprotein
-
Sief I., Coulon P., Rollin P.E., Flamand A. Rabies virus virulence: effect on pathogenicity and sequence characterization of mutations affecting antigenic site III of the glycoprotein. Journal of Virology 1985, 53:926-935.
-
(1985)
Journal of Virology
, vol.53
, pp. 926-935
-
-
Sief, I.1
Coulon, P.2
Rollin, P.E.3
Flamand, A.4
-
59
-
-
0035925713
-
Plant-based vaccines: unique advantages
-
Streatfield S.J., Jilka J.M., Hood E.E., et al. Plant-based vaccines: unique advantages. Vaccine 2001, 19:2742-2748.
-
(2001)
Vaccine
, vol.19
, pp. 2742-2748
-
-
Streatfield, S.J.1
Jilka, J.M.2
Hood, E.E.3
-
60
-
-
0028997136
-
Biological and immunogenic properties of a canarypoxrabies recombinant, ALVAC-RG (vCP65) in non-avian species
-
Taylor J., Meignier B., Tartaglia J., et al. Biological and immunogenic properties of a canarypoxrabies recombinant, ALVAC-RG (vCP65) in non-avian species. Vaccine 1995, 13:539-549.
-
(1995)
Vaccine
, vol.13
, pp. 539-549
-
-
Taylor, J.1
Meignier, B.2
Tartaglia, J.3
-
61
-
-
0026085737
-
Efficacy studies on a canarypox-rabies recombinant virus
-
Taylor J., Trimarchi C., Weinberg R., et al. Efficacy studies on a canarypox-rabies recombinant virus. Vaccine 1991, 9:190-193.
-
(1991)
Vaccine
, vol.9
, pp. 190-193
-
-
Taylor, J.1
Trimarchi, C.2
Weinberg, R.3
-
62
-
-
0024267575
-
Recombinant fowlpox virus inducing protective immunity in non-avian species
-
Taylor J., Weinberg R., Languet B., Desmettre P., Paoletti E. Recombinant fowlpox virus inducing protective immunity in non-avian species. Vaccine 1988, 6:497-503.
-
(1988)
Vaccine
, vol.6
, pp. 497-503
-
-
Taylor, J.1
Weinberg, R.2
Languet, B.3
Desmettre, P.4
Paoletti, E.5
-
63
-
-
0034659615
-
Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titer of neutralizing antibodies
-
Tims T., Briggs D.J., Davis R.D., et al. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titer of neutralizing antibodies. Vaccine 2000, 18:2804-2807.
-
(2000)
Vaccine
, vol.18
, pp. 2804-2807
-
-
Tims, T.1
Briggs, D.J.2
Davis, R.D.3
-
64
-
-
0024460097
-
Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice
-
Tuffereau C., Leblois H., Bennejean J., Coulon P., Lafay F., Flamand A. Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 1989, 172:206-212.
-
(1989)
Virology
, vol.172
, pp. 206-212
-
-
Tuffereau, C.1
Leblois, H.2
Bennejean, J.3
Coulon, P.4
Lafay, F.5
Flamand, A.6
-
65
-
-
0032869533
-
An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species
-
Vos A., Neubert A., Aylan O., et al. An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species. Epidemiology and Infections 1999, 123:165-175.
-
(1999)
Epidemiology and Infections
, vol.123
, pp. 165-175
-
-
Vos, A.1
Neubert, A.2
Aylan, O.3
-
66
-
-
0034852390
-
Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration
-
Vos A., Neubert A., Pommerening E., et al. Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration. Journal of General Virology 2001, 82:2191-2197.
-
(2001)
Journal of General Virology
, vol.82
, pp. 2191-2197
-
-
Vos, A.1
Neubert, A.2
Pommerening, E.3
-
67
-
-
0030951410
-
The use of an E1-deleted, replicative-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus
-
Wang Y., Xiang Z., Pasquini S., Ertl H.C.J. The use of an E1-deleted, replicative-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus. Journal of Virology 1997, 71:3677-3683.
-
(1997)
Journal of Virology
, vol.71
, pp. 3677-3683
-
-
Wang, Y.1
Xiang, Z.2
Pasquini, S.3
Ertl, H.C.J.4
-
68
-
-
25144513480
-
Attenuated rabies virus activates, while pathogenic rabies virus evades, the host immune responses in the central nervous system
-
Wang Z.W., Sarmento L., Wang Y., et al. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host immune responses in the central nervous system. Journal of Virology 2005, 79:12554-12565.
-
(2005)
Journal of Virology
, vol.79
, pp. 12554-12565
-
-
Wang, Z.W.1
Sarmento, L.2
Wang, Y.3
-
71
-
-
0025784469
-
Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions
-
Wold W.S.M., Gooding L.R. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 1991, 184:1-8.
-
(1991)
Virology
, vol.184
, pp. 1-8
-
-
Wold, W.S.M.1
Gooding, L.R.2
-
72
-
-
0036187846
-
Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product
-
Xiang Z.Q., Gao G.P., Reyes-Sandoval A., et al. Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product. Journal of Virology 2002, 76:2667-2675.
-
(2002)
Journal of Virology
, vol.76
, pp. 2667-2675
-
-
Xiang, Z.Q.1
Gao, G.P.2
Reyes-Sandoval, A.3
-
73
-
-
0141566356
-
Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier
-
Xiang Z.Q., Gao G.P., Reyes-Sandoval A., Li Y., Wilson J.M., Ertl H.C.J. Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier. Journal of Virology 2003, 77:10780-10789.
-
(2003)
Journal of Virology
, vol.77
, pp. 10780-10789
-
-
Xiang, Z.Q.1
Gao, G.P.2
Reyes-Sandoval, A.3
Li, Y.4
Wilson, J.M.5
Ertl, H.C.J.6
-
74
-
-
0029061812
-
Immune responses to nucleic acid vaccines to rabies virus
-
Xiang Z.Q., Spitalnik S., Cheng J., Erikson J., Wojczyk B., Ertl H.C.J. Immune responses to nucleic acid vaccines to rabies virus. Virology 1995, 209:569-579.
-
(1995)
Virology
, vol.209
, pp. 569-579
-
-
Xiang, Z.Q.1
Spitalnik, S.2
Cheng, J.3
Erikson, J.4
Wojczyk, B.5
Ertl, H.C.J.6
-
75
-
-
0028244596
-
Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus
-
Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., Ertl H.C.J. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 1994, 199:132-140.
-
(1994)
Virology
, vol.199
, pp. 132-140
-
-
Xiang, Z.Q.1
Spitalnik, S.2
Tran, M.3
Wunner, W.H.4
Cheng, J.5
Ertl, H.C.J.6
-
76
-
-
0029951519
-
A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier
-
Xiang Z.Q., Yang Y., Wilson J.M., Ertl H.C.J. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 1996, 219:220-227.
-
(1996)
Virology
, vol.219
, pp. 220-227
-
-
Xiang, Z.Q.1
Yang, Y.2
Wilson, J.M.3
Ertl, H.C.J.4
-
77
-
-
0028484704
-
MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses
-
Yang Y., Ertl H.C.J., Wilson J.M. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994, 1:433-442.
-
(1994)
Immunity
, vol.1
, pp. 433-442
-
-
Yang, Y.1
Ertl, H.C.J.2
Wilson, J.M.3
-
78
-
-
0037135676
-
Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine
-
Yusibov V., Hooper D.C., Spitsin S.V., Fleysh N., Kean R.B., Mikheeva T. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 2002, 20:3155-3164.
-
(2002)
Vaccine
, vol.20
, pp. 3155-3164
-
-
Yusibov, V.1
Hooper, D.C.2
Spitsin, S.V.3
Fleysh, N.4
Kean, R.B.5
Mikheeva, T.6
-
79
-
-
0030951339
-
Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1
-
Yusibov V., Modelska A., Steplewski K., et al. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proceedings of the National Academy of Sciences USA 1997, 94:5784-5788.
-
(1997)
Proceedings of the National Academy of Sciences USA
, vol.94
, pp. 5784-5788
-
-
Yusibov, V.1
Modelska, A.2
Steplewski, K.3
-
80
-
-
0032952345
-
Plant viral vectors based on tobamoviruses
-
Yusibov V., Shivprasad S., Turpen T.H., Dawson W., Koprowski H. Plant viral vectors based on tobamoviruses. Current Topics in Microbiology and Immunology 1999, 240:81-94.
-
(1999)
Current Topics in Microbiology and Immunology
, vol.240
, pp. 81-94
-
-
Yusibov, V.1
Shivprasad, S.2
Turpen, T.H.3
Dawson, W.4
Koprowski, H.5
-
81
-
-
33749255914
-
A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus
-
Zhou D., Cun A., Li Y., Xiang Z.Q., Ertl H.C.J. A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus. Molecular Therapy 2006, 14:662-672.
-
(2006)
Molecular Therapy
, vol.14
, pp. 662-672
-
-
Zhou, D.1
Cun, A.2
Li, Y.3
Xiang, Z.Q.4
Ertl, H.C.J.5
|